iuc1ep2 | Knowledge4COVID-19

Property	Value
?:abstract	SOURCE CITATION Mantsiou C, Karagiannis T, Kakotrichi P, et al. Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2020;22:1857-68. 32476254.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/8iuc1ep2_hasAnnotation_C0013227> <https://research.tib.eu/covid-19/entity/8iuc1ep2_hasAnnotation_C0061355>
?:creator	<https://research.tib.eu/covid-19/entity/Tanner%2C_Michael>
?:doi	<https://research.tib.eu/covid-19/entity/10.7326/acpj202011170-052>
?:doi	10.7326/acpj202011170-052
?:journal	Annals_of_internal_medicine
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/33197349>
?:pmid	33197349
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	Medline
?:title	In type 2 diabetes, GLP-1 RA plus SGLT2 inhibitor vs. either drug alone reduces HbA1c and SBP and may reduce body weight.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-17

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/8iuc1ep2>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/8iuc1ep2>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all